Management of Ovarian Remnant Syndrome

Victoria P.C. Orford; Raphael Kuhn

doi:10.1111/j.1479-828x.1996.tb02195.x

Management of Ovarian Remnant Syndrome

Victoria P.C. Orford, Raphael Kuhn

In: Australian and New Zealand Journal of Obstetrics and Gynaecology · 1996 · vol. 36(4) , pp. 468–471 · doi:10.1111/j.1479-828x.1996.tb02195.x · PMID:9006836 · W2048823044

article OA: closed CC0 ⤵ 1 in-corpus citation

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-07, 2026-07-29 ⓘ

Ovarian remnant syndrome, caused by functional ovarian tissue after oophorectomy, presents with chronic pelvic pain or dyspareunia, and is best treated with surgical removal after potential hormonal suppression or diagnostic ovarian stimulation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ovarian remnant syndrome is a rare condition which develops when functional ovarian tissue which is left in situ after intended bilateral oophorectomy produces clinically significant symptoms, namely chronic pelvic pain and/or dyspareunia. Women with this syndrome may have a pelvic mass palpable on bimanual examination, or visible on transvaginal ultrasound. However, visualization of an ovarian remnant is sometimes difficult because it is small and multiple previous pelvic operations have usually produced dense adhesions and distorted pelvic anatomy. Identification of these remnants may be facilitated by ovarian stimulation. Surgical removal is the optimal treatment, but hormonal suppression of ovarian activity may provide temporary relief of pain.